Related references
Note: Only part of the references are listed.Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
D. J. McGrail et al.
ANNALS OF ONCOLOGY (2021)
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Fabio Conforti et al.
CLINICAL CANCER RESEARCH (2021)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
Fabio Conforti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases
Simon Milette et al.
NATURE COMMUNICATIONS (2019)
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti et al.
LANCET ONCOLOGY (2018)
Landscape of Tumor Mutation Load, Mismatch RepairDeficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
Mohamed E. Salem et al.
MOLECULAR CANCER RESEARCH (2018)
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system
Fabio Conforti et al.
Oncotarget (2018)
Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma
Dakai Xiao et al.
ONCOTARGET (2016)
SeXX Matters in Infectious Disease Pathogenesis
Landon G. vom Steeg et al.
PLOS PATHOGENS (2016)
Sex differences and hormonal effects on gut microbiota composition in mice
Elin Org et al.
GUT MICROBES (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Estrogen receptors regulate innate immune cells and signaling pathways
Susan Kovats
CELLULAR IMMUNOLOGY (2015)
Gender Disparity and Mutation Burden in Metastatic Melanoma
Sameer Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Gender Disparity and Mutation Burden in Metastatic Melanoma
Sameer Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
Janet G. M. Markle et al.
SCIENCE (2013)
Interpretation of Subgroup Analyses in Randomized Trials: Heterogeneity Versus Secondary Interventions
Tyler J. VanderWeele et al.
ANNALS OF INTERNAL MEDICINE (2011)
Sex Disparities in Cancer Mortality and Survival
Michael B. Cook et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
Pei-Yi Lin et al.
JOURNAL OF IMMUNOLOGY (2010)
The Xs and Y of immune responses to viral vaccines
Sabra L. Klein et al.
LANCET INFECTIOUS DISEASES (2010)
The X chromosome in immune functions: when a chromosome makes the difference
Claude Libert et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Sex Disparities in Cancer Incidence by Period and Age
Michael B. Cook et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Membrane Estrogen Receptor Regulates Experimental Autoimmune Encephalomyelitis through Up-regulation of Programmed Death 1
Chunhe Wang et al.
JOURNAL OF IMMUNOLOGY (2009)
Skin cancer-related prevention and screening behaviors: a review of the literature
Nadine A. Kasparian et al.
JOURNAL OF BEHAVIORAL MEDICINE (2009)
Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)
Magdalena J. Polanczyk et al.
INTERNATIONAL IMMUNOLOGY (2007)
Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway
Magdalena J. Polanczyk et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
